Statins in nervous system-associated diseases: angels or devils?

Author： Lei Q.   Peng W. N.   You H.   Hu Z. P.   Lu W.  

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.69, Iss.6, 2014-06, pp. : 448-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gene Therapy for Peripheral Nervous System Diseases

By  

Current Gene Therapy, Vol. 7, Iss. 4, 2007-01 ,pp. : 239-248

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potentials of neurotrophic factors for diseases of the nervous system

By Gao W-Q.   Weil R.J.   Dugich-Djordjevic M.   Lu B.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. : 325-338

Informa Healthcare

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors in Central Nervous System Diseases

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 538-616

Bentham Science Publishers

Access to resources Recommend Favorite

Aptamers: Selection, Modification and Application to Nervous System Diseases

By  

Current Medicinal Chemistry, Vol. 18, Iss. 27, 2011-09 ,pp. : 4159-4168

Bentham Science Publishers

Access to resources Recommend Favorite

Thiazolidine: A Potent Candidate for Central Nervous System Diseases

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 1, 2017-02 ,pp. : 26-29

Bentham Science Publishers

Access to resources Recommend Favorite